These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38739934)

  • 21. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDP-43-stratified single-cell proteomic profiling of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis.
    Guise AJ; Misal SA; Carson R; Boekweg H; Watt DV; Truong T; Liang Y; Chu JH; Welsh NC; Gagnon J; Payne SH; Plowey ED; Kelly RT
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative patterns of motor cortex proteinopathy across ALS genotypes.
    Nolan M; Scott C; Gamarallage MP; Lunn D; Carpenter K; McDonough E; Meyer D; Kaanumalle S; Santamaria-Pang A; Turner MR; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2020 Jul; 8(1):98. PubMed ID: 32616036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?
    Mimuro M; Yoshida M; Kuzuhara S; Kokubo Y
    Neuropathology; 2018 Feb; 38(1):98-107. PubMed ID: 29063640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy.
    Tsitkanou S; Della Gatta PA; Abbott G; Wallace MA; Lindsay A; Gerlinger-Romero F; Walker AK; Foletta VC; Russell AP
    Neurobiol Dis; 2022 Jan; 162():105559. PubMed ID: 34774794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
    Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS.
    Waters S; Swanson MEV; Dieriks BV; Zhang YB; Grimsey NL; Murray HC; Turner C; Waldvogel HJ; Faull RLM; An J; Bowser R; Curtis MA; Dragunow M; Scotter E
    Acta Neuropathol Commun; 2021 Aug; 9(1):144. PubMed ID: 34446086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant TDP-43 phosphorylation: a key wind gap from TDP-43 to TDP-43 proteinopathy.
    Huang ZQ; Ba ZS; Huang NQ; Li YY; Luo Y
    Ibrain; 2021 Jun; 7(2):119-131. PubMed ID: 37786905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
    Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
    Liu YC; Chiang PM; Tsai KJ
    Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TDP-43-stratified single-cell proteomics of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis.
    Guise AJ; Misal SA; Carson R; Chu JH; Boekweg H; Van Der Watt D; Welsh NC; Truong T; Liang Y; Xu S; Benedetto G; Gagnon J; Payne SH; Plowey ED; Kelly RT
    Cell Rep; 2024 Jan; 43(1):113636. PubMed ID: 38183652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.
    Scotter EL; Chen HJ; Shaw CE
    Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
    Prasad A; Bharathi V; Sivalingam V; Girdhar A; Patel BK
    Front Mol Neurosci; 2019; 12():25. PubMed ID: 30837838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
    Gao J; Wang L; Yan T; Perry G; Wang X
    Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
    Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP
    J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.